Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)
China
· Delayed Price · Currency is CNY 4.900
+0.100 (2.08%)
At close: Mar 10, 2026
SHE:002793 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 2,457 | 2,615 | 2,329 | 3,470 | 6,370 | 6,011 | Upgrade
|
| Other Revenue | 32.7 | 32.7 | 35.27 | 117.61 | 108.29 | 85.15 | Upgrade
|
| Revenue | 2,490 | 2,647 | 2,364 | 3,588 | 6,478 | 6,096 | Upgrade
|
| Revenue Growth (YoY) | 2.96% | 11.99% | -34.11% | -44.62% | 6.26% | -19.67% | Upgrade
|
| Cost of Revenue | 1,362 | 1,607 | 1,340 | 2,694 | 3,232 | 2,848 | Upgrade
|
| Gross Profit | 1,127 | 1,040 | 1,024 | 893.98 | 3,246 | 3,248 | Upgrade
|
| Selling, General & Admin | 1,209 | 1,418 | 1,338 | 2,229 | 2,234 | 2,341 | Upgrade
|
| Research & Development | 101.5 | 87.41 | 112.27 | 204.73 | 320.95 | 361.27 | Upgrade
|
| Other Operating Expenses | 6.16 | -2.01 | -1.2 | 40.17 | 74.48 | 67.09 | Upgrade
|
| Operating Expenses | 1,282 | 1,517 | 1,504 | 2,494 | 2,726 | 2,832 | Upgrade
|
| Operating Income | -154.5 | -476.89 | -479.63 | -1,600 | 519.59 | 416.42 | Upgrade
|
| Interest Expense | -60.56 | -64.38 | -75.97 | -122.67 | -105.18 | -50.37 | Upgrade
|
| Interest & Investment Income | 4.81 | 6.3 | 24.84 | 176.24 | 9.87 | 12.78 | Upgrade
|
| Currency Exchange Gain (Loss) | 2.09 | 2.09 | 4.19 | -8.88 | 0.64 | -0.53 | Upgrade
|
| Other Non Operating Income (Expenses) | -18.76 | -1.31 | -0.87 | -2.06 | 5.2 | 0.14 | Upgrade
|
| EBT Excluding Unusual Items | -226.93 | -534.19 | -527.45 | -1,557 | 430.11 | 378.44 | Upgrade
|
| Gain (Loss) on Sale of Investments | -208.64 | -216.58 | -4.05 | 2.01 | -3.26 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 4.93 | 0.24 | -12.18 | 1.74 | -3.31 | -5.42 | Upgrade
|
| Asset Writedown | -207.22 | -229.97 | -56.64 | -7.85 | -0.72 | -7.1 | Upgrade
|
| Legal Settlements | - | - | - | - | - | -2.17 | Upgrade
|
| Other Unusual Items | 27.65 | 27.65 | -3.8 | 98.25 | 62.38 | 43.54 | Upgrade
|
| Pretax Income | -610.2 | -952.85 | -604.11 | -1,463 | 485.2 | 407.3 | Upgrade
|
| Income Tax Expense | 90.9 | 99.4 | 164.81 | -205.64 | 63.55 | 66.33 | Upgrade
|
| Earnings From Continuing Operations | -701.1 | -1,052 | -768.92 | -1,257 | 421.65 | 340.97 | Upgrade
|
| Minority Interest in Earnings | 23.9 | 86.76 | 107.78 | 32.37 | -15.55 | -20.27 | Upgrade
|
| Net Income | -677.2 | -965.5 | -661.14 | -1,225 | 406.1 | 320.7 | Upgrade
|
| Net Income to Common | -677.2 | -965.5 | -661.14 | -1,225 | 406.1 | 320.7 | Upgrade
|
| Net Income Growth | - | - | - | - | 26.63% | -49.41% | Upgrade
|
| Shares Outstanding (Basic) | 1,056 | 1,061 | 1,084 | 1,424 | 1,450 | 1,458 | Upgrade
|
| Shares Outstanding (Diluted) | 1,056 | 1,061 | 1,084 | 1,424 | 1,450 | 1,458 | Upgrade
|
| Shares Change (YoY) | -0.78% | -2.11% | -23.91% | -1.79% | -0.51% | 31.07% | Upgrade
|
| EPS (Basic) | -0.64 | -0.91 | -0.61 | -0.86 | 0.28 | 0.22 | Upgrade
|
| EPS (Diluted) | -0.64 | -0.91 | -0.61 | -0.86 | 0.28 | 0.22 | Upgrade
|
| EPS Growth | - | - | - | - | 27.27% | -61.40% | Upgrade
|
| Free Cash Flow | 240.65 | -273.2 | 224.5 | -1,134 | -188.4 | -393.64 | Upgrade
|
| Free Cash Flow Per Share | 0.23 | -0.26 | 0.21 | -0.80 | -0.13 | -0.27 | Upgrade
|
| Dividend Per Share | - | - | - | - | 0.030 | 0.050 | Upgrade
|
| Dividend Growth | - | - | - | - | -40.00% | - | Upgrade
|
| Gross Margin | 45.28% | 39.30% | 43.33% | 24.92% | 50.10% | 53.28% | Upgrade
|
| Operating Margin | -6.21% | -18.01% | -20.29% | -44.59% | 8.02% | 6.83% | Upgrade
|
| Profit Margin | -27.20% | -36.47% | -27.97% | -34.14% | 6.27% | 5.26% | Upgrade
|
| Free Cash Flow Margin | 9.66% | -10.32% | 9.50% | -31.61% | -2.91% | -6.46% | Upgrade
|
| EBITDA | 36.86 | -285.6 | -288.45 | -1,394 | 705.83 | 587.12 | Upgrade
|
| EBITDA Margin | 1.48% | -10.79% | -12.20% | -38.87% | 10.90% | 9.63% | Upgrade
|
| D&A For EBITDA | 191.37 | 191.29 | 191.18 | 205.33 | 186.24 | 170.69 | Upgrade
|
| EBIT | -154.5 | -476.89 | -479.63 | -1,600 | 519.59 | 416.42 | Upgrade
|
| EBIT Margin | -6.21% | -18.01% | -20.29% | -44.59% | 8.02% | 6.83% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 13.10% | 16.29% | Upgrade
|
| Revenue as Reported | 2,490 | 2,647 | 2,364 | 3,588 | 6,478 | 6,096 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.